H. Bisgaard (Copenhagen, Denmark), P. Le Souef (Perth, Australia)
Inhaler devices for children with asthma: how well are we following the guidelines?
F. Child, S. Davies, S. Clayton, A. A. Fryer, W. Lenney (Stoke-on-Trent, United Kingdom)
|  |
Anti-inflammatory effect of an additional therapy with Montelukast on steroid-dependent children with asthma
E. Strauch, S. Moske, G. Thoma, G. Ihorst, K. Storm van's Gravesande, J. Kuehr (Freiburg, Germany)
| |
No differences in bronchodilation after inhalation of dry powder β2-agonists in asthmatic children
A. Zapleta, J. Rydlová, J. Hak (Prague, Czech Republic)
| |
Measurement of inspiratory flow through 3 different dry powder inhalation devices using In-check in asthmatic children
K. N. Desager, J. Geldhof, R. Claes, W. De Backer (Antwerp, Belgium)
| |
Discriminative capacity of bronchodilator response measured by three different lung function techniques in asthmatic and healthy children of 2-5 years
K. G. Nielsen, H. Bisgaard (Copenhagen, Denmark)
| |
Repeatability of bronchial responsiveness to mannitol dry powder in children with asthma
J. Barben, M. Roberts, J. B. Carlin, C. F. Robertson (Melbourne, Australia)
| |
Diagnostic value of determining static versus dynamic lung volumes in the recognition of airways responsiveness to a bronchodilator in asthmatic children
L. Mappa, A. Nigro, R. Giorgio, A. Balenzano, R. Camodeca, V. Bosco, N. Rigillo (Bari, Italy)
| |
Drug delivery from inhalation devices is dependent on face mask seal and the child's breathing pattern
G. C. Smaldone, E. Berg, L. Morra, K. Nikander (New York, United States Of America; Lund, Sweden)
| |
Impact of inspiratory delay and valved holding chamber (VHC) material on drug delivery
E. Berg, K. Nikander, L. Morra, G. C. Smaldone (Lund, Sweden; New York, United States Of America)
| |
In vitro testing of inhalation devices with face masks
K. Nikander, E. Berg, L. Morra, G. C. Smaldone (Lund, Sweden; New York, United States Of America)
| |
Comparison of carers' ability to use aerosol delivery systems in young children
S. Ritson, M. L. Everard, J. Denyer, I. Prince (Sheffield, Bognor Regis, United Kingdom)
| |
Evidence that a new incentive spacer device encourages children to take their asthma medication
G. Chaney, P. Le Souef, S. Devadason, B. Clements, P. Watt (Perth, Australia)
| |
Rapid and sustained improvements in lung function and symptom control with budesonide/formoterol in adolescent asthma
| |
Age-dependent bronchial reactivity (BR) to methacholine (Mch) in childhood
C. Moreau-Colson, C. Schweitzer, C. Chone, F. Marchal (Vandœuvre lès Nancy, France)
| |
Assessment of lung epithelial permeability by 99mTc-DTPA and its relation to pulmonary functions in asthmatic children
E. M. Fouda, M. Y. El-Seify, O. A. Abdel Salam, A. K. Ali (Cairo, Egypt)
| |
Anti-inflammatory treatment in 5-10-year-old mildly symptomatic children with asthma: can we objectively measure the effect?
H. G. M. Arets, A. W. A. Kamps, H. J. L. Brackel, P. G. H. Mulder, N. A. V. Vermue, C. K. van der Ent (Utrecht, Zwolle, Rotterdam, Zeist, The Netherlands)
| |
Free running asthma screening test (FRAST): a useful tool or a waste of time?
F. Kirvassilis, E. Hatziagorou, K. Tselepis, M. Alexandridis, J. Tsanakas (Thessaloniki, Greece)
| |
Efficacy of single-dose Montelukast on exercise-induced bronchoconstriction in children
D. G. Peroni, G. L. Piacentini, A. Loiacono, S. Costella, A. Pietrobelli, W. De Gasperi, R. Micciolo, A. L. Boner (Italy, Misurina, Trento, Italy)
| |
Effect of long-term treatment with inhaled furosemide and nedocromil sodium on exercise-induced broncho-obstruction in asthmatic children
L. Shostakovich-Koretskaya, A. Cherginets (Dnipropetrovsk, Ukraine)
| |